These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 35833696

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adherence, health care utilization, and costs between long-acting injectable and oral antipsychotic medications in South Carolina Medicaid beneficiaries with schizophrenia.
    Cai C, Kozma C, Patel C, Benson C, Yunusa I, Zhao P, Reeder G, Narasimhan M, Bank RL.
    J Manag Care Spec Pharm; 2024 Jun; 30(6):549-559. PubMed ID: 38824623
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
    Marcus SC, Zummo J, Pettit AR, Stoddard J, Doshi JA.
    J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
    Greene M, Yan T, Chang E, Hartry A, Touya M, Broder MS.
    J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics on Time to Rehospitalization Within 1 Year of Discharge in Elderly Patients With Schizophrenia.
    Lin CH, Chen FC, Chan HY, Hsu CC.
    Am J Geriatr Psychiatry; 2020 Jan; 28(1):23-30. PubMed ID: 31481273
    [Abstract] [Full Text] [Related]

  • 11. Treatment Patterns, Healthcare Resource Utilization and Costs Among Schizophrenia Patients Treated with Long-Acting Injectable Versus Oral Antipsychotics.
    Shah A, Xie L, Kariburyo F, Zhang Q, Gore M.
    Adv Ther; 2018 Nov; 35(11):1994-2014. PubMed ID: 30269292
    [Abstract] [Full Text] [Related]

  • 12. Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics and Suicide and All-Cause Mortality in Patients With Newly Diagnosed Schizophrenia.
    Huang CY, Fang SC, Shao YJ.
    JAMA Netw Open; 2021 May 03; 4(5):e218810. PubMed ID: 33974056
    [Abstract] [Full Text] [Related]

  • 13. In-Hospital Use of Long-Acting Injectable Antipsychotics and Readmission Risk in Patients With First-Admission Schizophrenia in Taiwan.
    Chen W, Wu CS, Liu CC, Kuo PH, Chan HY, Lin YH, Chung YE, Chen WJ.
    JAMA Netw Open; 2024 Jun 03; 7(6):e2417006. PubMed ID: 38884998
    [Abstract] [Full Text] [Related]

  • 14. Racial disparities in utilization of first-generation versus second-generation long-acting injectable antipsychotics in Medicaid beneficiaries with schizophrenia.
    Pesa J, Liu Z, Fu AZ, Campbell AK, Grucza R.
    Schizophr Res; 2023 Nov 03; 261():170-177. PubMed ID: 37778124
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis.
    Vita G, Tavella A, Ostuzzi G, Tedeschi F, De Prisco M, Segarra R, Solmi M, Barbui C, Correll CU.
    Ther Adv Psychopharmacol; 2024 Nov 03; 14():20451253241257062. PubMed ID: 38831918
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics.
    Mahlich J, Olbrich K, Wilk A, Wimmer A, Wolff-Menzler C.
    Clin Drug Investig; 2021 Jan 03; 41(1):99-113. PubMed ID: 33331979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.